Smallpox and its eradication, Geneva: World Health Organization, 1988. ,
The Looming Threat of Bioterrorism, Science, vol.283, issue.5406, pp.1279-82, 1999. ,
DOI : 10.1126/science.283.5406.1279
Progressive Vaccinia, Clinical Infectious Diseases, vol.36, issue.6, pp.766-74, 2003. ,
DOI : 10.1086/374244
Myocarditis: the unexpected return of smallpox vaccine adverse events, The Lancet, vol.362, issue.9393, pp.1345-1351, 2003. ,
DOI : 10.1016/S0140-6736(03)14674-0
Smallpox Vaccination: A Review, Part II. Adverse Events, Clinical Infectious Diseases, vol.37, issue.2, pp.251-71, 2003. ,
DOI : 10.1086/375825
Complications of smallpox vaccination, N Engl J Med, vol.969, issue.281, pp.1201-1209, 1968. ,
Pathogenesis and potential antiviral therapy of complications of smallpox vaccination, Antiviral Research, vol.58, issue.2, 2003. ,
DOI : 10.1016/S0166-3542(03)00008-1
Smallpox vaccination reactions, prophylaxis, and therapy of complications, Pediatrics, vol.55, pp.342-349, 1975. ,
Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) Disease, New England Journal of Medicine, vol.316, issue.11, pp.673-679, 1987. ,
DOI : 10.1056/NEJM198703123161106
Studies smallpox and complications of smallpox vaccination, Pediatrics, vol.26, pp.176-89, 1960. ,
Severe Eczema Vaccinatum in a Household Contact of a Smallpox Vaccinee, Clinical Infectious Diseases, vol.46, issue.10, pp.1555-61, 2008. ,
DOI : 10.1086/587668
ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine, Expert Opinion on Investigational Drugs, vol.55, issue.4, pp.555-64, 2008. ,
DOI : 10.1086/511828
The new ACAM2000??? vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks, Expert Review of Vaccines, vol.8, issue.7, pp.841-50, 2009. ,
DOI : 10.1586/erv.09.55
ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile, Drug Design, Development and Therapy, vol.4, pp.71-80, 2010. ,
DOI : 10.2147/DDDT.S3687
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax?? in healthy vaccinia-naive adults, Vaccine, vol.27, issue.10, pp.1637-1681, 2009. ,
DOI : 10.1016/j.vaccine.2008.11.079
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge, Vaccine, vol.26, issue.4, pp.581-589, 2008. ,
DOI : 10.1016/j.vaccine.2007.10.063
Adverse Events Following Smallpox Vaccination With ACAM2000 in a Military Population, Archives of Dermatology, vol.146, issue.6, pp.656-61, 2010. ,
DOI : 10.1001/archdermatol.2010.46
A novel, cell culture-derived smallpox vaccine in vaccinia-na??ve adults, Vaccine, vol.23, issue.25, pp.3301-3310, 2005. ,
DOI : 10.1016/j.vaccine.2005.01.079
The Future of smallpox vaccination: is MVA the key?, Med Immunol, vol.4, issue.2, 2005. ,
LC16m8: An attenuated smallpox vaccine, Vaccine, vol.24, issue.47-48, pp.7009-7031, 2006. ,
DOI : 10.1016/j.vaccine.2006.03.087
An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection, Journal of Virology, vol.79, issue.18, pp.11873-91, 2005. ,
DOI : 10.1128/JVI.79.18.11873-11891.2005
LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox, Journal of Virology, vol.80, issue.11, pp.5179-88, 2006. ,
DOI : 10.1128/JVI.02642-05
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge, Vaccine, vol.24, issue.17, pp.3686-94, 2006. ,
DOI : 10.1016/j.vaccine.2005.03.029
Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8, JAMA, vol.301, issue.10, pp.1025-1058, 2009. ,
DOI : 10.1001/jama.2009.289
Comparative Evaluation of the Immune Responses and Protection Engendered by LC16m8 and Dryvax Smallpox Vaccines in a Mouse Model, Clinical and Vaccine Immunology, vol.16, issue.9, 2009. ,
DOI : 10.1128/CVI.00040-09
The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis), Laboratory Investigation, vol.47, issue.12, pp.1581-600, 2001. ,
DOI : 10.1084/jem.185.6.1131
Smallpox vaccine???induced antibodies are necessary and sufficient for protection against monkeypox virus, Nature Medicine, vol.23, issue.7, pp.740-747, 2005. ,
DOI : 10.1016/S0042-6822(02)00038-7
Preexisting Infection with Human T-Cell Lymphotropic Virus Type 2 neither Exacerbates nor Attenuates Simian Immunodeficiency Virus SIVmac251 Infection in Macaques, Journal of Virology, vol.84, issue.6, pp.3043-58, 2010. ,
DOI : 10.1128/JVI.01655-09
URL : https://hal.archives-ouvertes.fr/pasteur-00589395
A Nonhuman Primate Model for the Selective Elimination of CD8+ Lymphocytes Using a Mouse-Human Chimeric Monoclonal Antibody, The American Journal of Pathology, vol.154, issue.6, pp.1923-1955, 1999. ,
DOI : 10.1016/S0002-9440(10)65450-8
Lineage-specific T-cell reconstitution following in vivo CD4+ and CD8+ lymphocyte depletion in nonhuman primates, Blood, vol.116, issue.5, pp.748-58, 2010. ,
DOI : 10.1182/blood-2010-01-263814
Modeling a Safer Smallpox Vaccination Regimen, for Human Immunodeficiency Virus Type 1???Infected Patients, in Immunocompromised Macaques, The Journal of Infectious Diseases, vol.188, issue.8, pp.1181-91, 2003. ,
DOI : 10.1086/378518
Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, vol.001, issue.50 10, pp.1-25, 2001. ,
Reduced Protection from Simian Immunodeficiency Virus SIVmac251 Infection Afforded by Memory CD8+ T Cells Induced by Vaccination during CD4+ T-Cell Deficiency, Journal of Virology, vol.82, issue.19, pp.9629-9667, 2008. ,
DOI : 10.1128/JVI.00893-08
Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination To Provide Complete Protection, Clinical and Vaccine Immunology, vol.14, issue.10, pp.1318-1345, 2007. ,
DOI : 10.1128/CVI.00148-07
Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, pp.1963-196826, 2003. ,
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8, Proceedings of the National Academy of Sciences, vol.102, issue.11, pp.4152-4159, 2005. ,
DOI : 10.1073/pnas.0406671102
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC554788
Skin Inflammation Arising from Cutaneous Regulatory T Cell Deficiency Leads to Impaired Viral Immune Responses, The Journal of Immunology, vol.185, issue.2, pp.1295-302, 2010. ,
DOI : 10.4049/jimmunol.0903144
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873154
Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum, The Journal of Experimental Medicine, vol.131, issue.6, pp.1219-1244, 2009. ,
DOI : 10.4049/jimmunol.176.12.7736
Modulation of Natural Killer Cell Activity in Patients with Atopic Dermatitis, Journal of Investigative Dermatology, vol.82, issue.1, pp.30-34, 1984. ,
DOI : 10.1111/1523-1747.ep12259055
Natural-killer-cell activity in atopic dermatitis, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.108, issue.5, pp.483-90, 1984. ,
DOI : 10.1007/BF00403731
Absence of T-regulatory cell expression and function in atopic dermatitis skin, Journal of Allergy and Clinical Immunology, vol.117, issue.1, pp.176-83, 2006. ,
DOI : 10.1016/j.jaci.2005.10.040
Circulating Foxp3+CD4+ cell numbers in atopic patients and healthy control subjects, Journal of Allergy and Clinical Immunology, vol.120, issue.4, pp.960-962, 2007. ,
DOI : 10.1016/j.jaci.2007.05.036
Tacrolimus ointment: a novel and effective topical treatment of localized atopic dermatitis in a rhesus macaque (Macaca mulatta), J Am Assoc Lab Anim Sci, vol.48, pp.307-318, 2009. ,